Work

Donanemab for Alzheimer Disease—Who Benefits and Who Is Harmed?

Year: 2023

Type: editorial

Source: JAMA

DOI: 10.1001/jama.2023.11704

Authors: Jennifer J. Manly, Kacie D. Deters

Institutions: Columbia University Irving Medical Center, University of California, Los Angeles

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Alzheimer's Association, National Institute on Aging, National Institute of Neurological Disorders and Stroke

OpenAlex ID: W4384560910

Cites: 14

Cited by: 61

Related to: 10